Effects of Ninjurin 2 polymorphisms on susceptibility to coronary heart disease

References

• Timmis A, Vardas P, Townsend N, et al. European society of cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43(8):716–799. doi: 10.1093/eurheartj/ehab892
   PubMed Web of Science ®Google Scholar
• World Health Organization. The top 10 causes of death. 20December2022. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death.
   Google Scholar
• Dai H, Much AA, Maor E, et al.: Global, regional, and national burden of ischaemic heart disease and its attributable risk factors, 1990-2017: results from the global burden of disease study 2017. Eur Heart J Qual Care Clin Outcomes 2022, 8(1):50–60. 10.1093/ehjqcco/qcaa076
   PubMed Web of Science ®Google Scholar
• Dugani SB, Moorthy MV, Li C, et al.: Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women. JAMA Cardiology 2021, 6(4):437–447. 10.1001/jamacardio.2020.7073
   PubMed Web of Science ®Google Scholar
• Bae JW, Woo SI, Lee J, et al., Lee WK: mHealth interventions for lifestyle and risk factor modification in coronary heart disease: randomized controlled trial. JMIR Mhealth Uhealth 2021, 9(9):e29928. 10.2196/29928
   PubMed Web of Science ®Google Scholar
• Tcheandjieu C, Zhu X, Hilliard AT, et al. Large-scale genome-wide association study of coronary artery disease in genetically diverse populations. Nature Med. 2022;28(8):1679–1692. doi: 10.1038/s41591-022-01891-3
   PubMed Web of Science ®Google Scholar
• Chen Z, Schunkert H: Genetics of coronary artery disease in the post-GWAS era. J Intern Med 2021, 290(5):980–992. 10.1111/joim.13362
   PubMed Web of Science ®Google Scholar
• Talmor-Barkan Y, Bar N, Shaul AA, et al. Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease. Nature Med. 2022;28(2):295–302. doi: 10.1038/s41591-022-01686-6
   PubMed Web of Science ®Google Scholar
• Khorrami M, Saneipour M, Moridnia A, et al. Interdependency of NINJ2 gene expression and polymorphism with susceptibility and response to interferon beta in patients with multiple sclerosis. Int J Neurosci. 2022;2022:1–6. doi:10.1080/00207454.2022.2102979
   Google Scholar
• Malekzadeh V, Azari I, Noroozi R, et al.: Genetic variants within Ninjurin 2 gene are associated with risk of ischemic stroke in Iranian population. Neurol Sci 2019, 40(12):2603–2607. 10.1007/s10072-019-04023-x
   PubMed Web of Science ®Google Scholar
• Sayad A, Ghafouri-Fard S, Omrani MD, et al.: Associations between two single-nucleotide polymorphisms in NINJ2 gene and risk of psychiatric disorders. J Mol Neurosci 2020, 70(2):236–245. 10.1007/s12031-019-01462-1
   PubMed Web of Science ®Google Scholar
• Wang P, Wang Y, Peng H, et al. Functional rare variant in a C/EBPbeta binding site in NINJ2 gene increases the risk of coronary artery disease. Aging. 2021;13(23):25393–25407. doi: 10.18632/aging.203755
   PubMedGoogle Scholar
• Nie F, Yu M, Liu M, et al.: NINJ2 gene polymorphisms and susceptibility to ischemic stroke: an updated meta-analysis. CNR 2019, 16(3):273–287. 10.2174/1567202616666190618125241
   Google Scholar
• Wang J, Fa J, Wang P, et al. NINJ2- a novel regulator of endothelial inflammation and activation. Cell Signal. 2017;35:231–241. doi: 10.1016/j.cellsig.2017.04.011
   PubMed Web of Science ®Google Scholar
• Corella D, Asensio EM, Coltell O, et al.: CLOCK gene variation is associated with incidence of type-2 diabetes and cardiovascular diseases in type-2 diabetic subjects: dietary modulation in the PREDIMED randomized trial. Cardiovasc Diabetol 2016, 15:4. 1 10.1186/s12933-015-0327-8
   PubMedGoogle Scholar
• Li X, Ma H, Li F, et al.: CDKN2BAS polymorphisms are associated with coronary artery disease in Chinese han population. Int J Clin Exp Pathol 2017, 10(1):804–810.
   Web of Science ®Google Scholar
• Chang W, Ma R, Zhang X, et al.: Impact of PPAP2B and TCF21 gene polymorphisms on risk of coronary heart disease in Chinese han population. Int J Clin Exp Pathol 2016, 9(2):1968–1974.
   Web of Science ®Google Scholar
• Sorosina M, Peroni S, Mascia E, et al.: Involvement of NINJ2 protein in inflammation and blood-brain barrier transmigration of monocytes in multiple sclerosis. Genes (Basel) 2022, 13(11):1946. 10.3390/genes13111946
   PubMed Web of Science ®Google Scholar
• Akinyelure OP, Colantonio LD, Chaudhary NS, et al. Inflammation biomarkers and incident coronary heart disease: the reasons for geographic and racial differences in stroke study. Am Heart J. 2022;253:39–47. doi: 10.1016/j.ahj.2022.07.001
   PubMed Web of Science ®Google Scholar
• Virani SS, Alonso A, Aparicio HJ, et al.: Heart disease and stroke statistics—2021 update. Circulation 2021, 143(8):e254–e743. 10.1161/CIR.0000000000000950
   PubMed Web of Science ®Google Scholar
• Mehta PK, Bess C, Elias-Smale S, et al. Gender in cardiovascular medicine: chest pain and coronary artery disease. Eur Heart J. 2019;40(47):3819–3826. doi: 10.1093/eurheartj/ehz784
   PubMed Web of Science ®Google Scholar
• Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285–292. doi: 10.1161/HYPERTENSIONAHA.119.14240
   PubMed Web of Science ®Google Scholar
• Arnold SV, Bhatt DL, Barsness GW, et al. Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American heart association. Circulation. 2020;141(19):e779–e806. doi: 10.1161/CIR.0000000000000766
   PubMed Web of Science ®Google Scholar
• Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet (London, England). 2022;399(10338):1876–1885. doi: 10.1016/S0140-6736(22)00122-2
   PubMed Web of Science ®Google Scholar